Return to Provider News

Administrative Policy AP-26 – COVID-19 Viral and Antibody Testing; Reimbursement Update Effective January 21, 2021

Audience: Physicians and Facilities

We advise you that Excellus BlueCross BlueShield Policy AP-26 COVID-19 Viral and Antibody Testing will be updated effective January 21, 2021, to define the coverage, reimbursement and billing guidelines for COVID-19 testing. You can access the individual policies by clicking here. Note: You must login with your username and password to access our administrative policies.

Related News
Inflectra Preferred Therapy for Medicare Advantage Members

Update to Administrative Policy AP-26 COVID-19 Viral and Antibody Testing and Supplies – Diagnosis Code B97.29

COVID-19 Vaccine Information and Updates to Administrative Policy 15

Updated Administrative Policy 30—Billing and Reimbursement Guidelines for Antigen Preparation for Allergy Immunology Effective January 1, 2021

Administrative Policy AP-26 – COVID-19 Viral and Antibody Testing and Supplies; Reimbursement Update Effective March 1, 2021

Category

Excellus

Policies & Clinical Criteria